What is the appropriate management for dyshidrotic eczema?

Management of Dyshidrotic Eczema

Start with high-potency topical corticosteroids applied twice daily as first-line therapy, combined with emollients and avoidance of irritants; if this fails after 1-4 weeks, escalate to oral PUVA therapy for hyperkeratotic forms or consider topical tacrolimus for rotation therapy in chronic cases.

First-Line Treatment Approach

Topical Corticosteroids

Topical corticosteroids are the cornerstone of dyshidrotic eczema management 1. Use the least potent preparation that controls the disease, but don't undertreated—moderately potent to potent steroids are typically required for palmoplantar eczema 1. Apply no more than twice daily, and plan for intermittent breaks when possible to minimize side effects like skin atrophy and pituitary-adrenal suppression 1.

Essential Supportive Measures

• Emollients: Apply after bathing to create a lipid film that prevents water loss 1
• Avoid irritants: Eliminate soaps and detergents; use dispersible cream as a soap substitute 1
• Keep nails short to minimize damage from scratching 1

Adjunctive Therapy for Pruritus

If severe itching disrupts sleep, add sedating antihistamines at bedtime only—non-sedating antihistamines have no value in eczema 1. Avoid daytime use, and be aware that tachyphylaxis can develop with prolonged use 1.

Second-Line Treatment: Phototherapy

PUVA Therapy

When topical therapy fails, oral PUVA is superior to UVB for hand eczema based on prospective controlled studies 2. The evidence shows:

• For hyperkeratotic eczema: Oral PUVA is significantly more effective than bath PUVA 3
• For dyshidrotic eczema: Bath PUVA may be preferable and achieves longer remission 3
• Clearance rates of 81-86% in uncontrolled studies 2

Important caveat: Topical PUVA has not demonstrated superiority over placebo or other treatments in randomized trials, despite some positive uncontrolled studies 2. The long-term risks include premature skin aging and potential malignancy, particularly with PUVA 1.

Alternative Second-Line Options

Topical Calcineurin Inhibitors

Tacrolimus 0.1% ointment shows comparable efficacy to mometasone furoate 0.1% in dyshidrotic palmar eczema, with >50% reduction in severity after 2 weeks 4. This offers an excellent option for rotational therapy with corticosteroids in chronic cases to avoid steroid-related side effects 4.

Specialized Interventions for Specific Presentations

If hyperhidrosis is a prominent feature (worsening in summer, excessive sweating):

• Consider intradermal botulinum toxin injections (mean 162 U BOTOX), which showed good to very good effect in 7 of 10 patients with vesicular hand dermatitis 5
• Alternative: Oxybutynin for coexistent hyperhidrosis can produce remarkable improvement 6

When to Treat Secondary Infection

Look for these clinical signs suggesting bacterial superinfection:

• Crusting or weeping
• Purulent exudate
• Pustules

If S. aureus infection is present: Use flucloxacillin as first choice; erythromycin for penicillin allergy 1. Send bacterial swabs with sensitivity testing for recurrent or non-responsive infections 7.

If eczema herpeticum is suspected (grouped punched-out erosions, vesiculation):

• Start oral acyclovir immediately—early treatment is critical 1
• Use IV acyclovir for ill, febrile patients 1
• This is a dermatologic urgency with significant morbidity if untreated 7

When to Refer to Specialist

Refer when 1:

• Failure to respond to moderately potent topical steroids in adults after adequate trial
• Diagnostic uncertainty
• Need for second-line treatments like phototherapy
• Consideration of systemic therapy

Third-Line: Systemic Therapy

For severe, refractory cases, systemic options include:

• Systemic corticosteroids: Limited role, never for maintenance, only to tide over severe flares 1
• Emerging biologics: Tralokinumab (anti-IL-13 monoclonal antibody) shows promise in case reports for severe dyshidrotic eczema 8

Critical Pitfalls to Avoid

1. Don't routinely use antibiotics for colonized but non-infected skin—this promotes resistance without improving outcomes 7
2. Don't undertreat due to steroid phobia—inadequate potency is a common cause of treatment failure 1
3. Don't use topical PUVA as first-line phototherapy—oral PUVA has better evidence 2
4. Don't miss eczema herpeticum—it requires immediate antiviral therapy 7